These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29886481)

  • 1. Growth Hormone Deficiency in the Transition Age.
    Loche S; Di Iorgi N; Patti G; Noli S; Giaccardi M; Olivieri I; Ibba A; Maghnie M
    Endocr Dev; 2018; 33():46-56. PubMed ID: 29886481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD.
    Hintz RL
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():631-5. PubMed ID: 12795365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase.
    Bazarra-Castro MÁ; Sievers C; Schwarz HP; Pozza SB; Stalla GK
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):507-10. PubMed ID: 23070828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
    Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
    J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD.
    Smyczyńska J; Stawerska R; Lewiński A; Hilczer M
    Endokrynol Pol; 2014; 65(5):334-41. PubMed ID: 25301482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure.
    Gelwane G; Garel C; Chevenne D; Armoogum P; Simon D; Czernichow P; Léger J
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3788-95. PubMed ID: 17666477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M; Payer J
    Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of the growth hormone (GH)-treated patients with diagnosis of GH deficiency (DGH) during transition from childhood to adulthood].
    Portes ES; Barbosa E
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):854-60. PubMed ID: 18797593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
    Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
    Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin levels in adolescents and young adults with growth hormone deficiency.
    Oswiecimska JM; Roczniak W; Roczniak RG; Malczyk Z; Chyra M; Mazur B; Ziora KT
    Neuro Endocrinol Lett; 2017 May; 38(2):107-116. PubMed ID: 28650604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult vs childhood onset GHD: is there a real clinical difference?
    van der Lely AJ; Janssen JM; Lamberts SW
    Growth Horm IGF Res; 1998 Feb; 8 Suppl A():21-3. PubMed ID: 10993586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.